Net sales in the quarter were $371 million compared with $357 million in last year’s December quarter (+4% core sales (1)). Net income from continuing operations was $36 million (diluted EPS from ...
February 10-11: BIO CEO & Investor Conference 2025. Daniel Vitt, Ph.D., Chief Executive Officer of Immunic, will participate in one-on-one meetings at this conference, taking place in New York.
Above is part of the Consolidated Summary Report of Mitsubishi UFJ Financial Group, Inc. under Japanese GAAP for the nine months ended December 31, 2024.
Fabrinet (NYSE: FN), a leading provider of advanced optical packaging and precision optical, electro-mechanical and electronic manufacturing services to original ...
Ellington Credit Company (NYSE: EARN) ("we") today reported the following preliminary fourth quarter financial results, and update on its portfolio and pending ...
Notice is given to the shareholders of eQ Plc to the Annual General Meeting (the “AGM”) to be held on 25 March 2025 at 5:00 p.m. at Sanoma House’s Eliel meeting room, Töölönlahdenkatu 2, 00100 ...